Loading...
XTAE
NISA
Market cap23mUSD
Jul 10, Last price  
781.60ILS
1D
0.00%
1Q
-10.83%
Jan 2017
-79.89%
Name

Nissan Medical Industries Ltd

Chart & Performance

D1W1MN
XTAE:NISA chart
P/E
17.01
P/S
0.11
EPS
0.46
Div Yield, %
23.29%
Shrs. gr., 5y
Rev. gr., 5y
-2.01%
Revenues
652m
-1.85%
466,789,000512,208,000529,957,000509,478,000584,389,000658,386,000605,462,000721,481,000668,372,000684,647,000733,914,000664,079,000651,777,000
Net income
4m
-47.22%
46,702,000603,00037,132,00017,909,00012,709,00025,102,00015,709,00056,846,00036,012,000-36,049,0005,649,0007,906,0004,173,000
CFO
50m
+87.54%
72,612,00077,113,000120,183,00044,178,00052,352,00085,837,00055,764,000122,569,00017,978,00011,674,000105,715,00026,833,00050,322,000
Dividend
Oct 05, 2025181.99999 ILS/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Established in 1984 and based in Tel Aviv-Yafo, Israel, Nissan Medical Industries Ltd, operating through its subsidiary, specializes in the production and distribution of spunlace non-woven textiles. These materials find extensive application across diverse sectors, including reusable and disposable consumer items, medical supplies, automotive manufacturing, infrastructure development, and various hygiene products. The company's market reach encompasses the United States, Canada, Europe, and Israel, with product sales managed through its network of sales agents.
URL
IPO date
Jan 01, 1993
Employees
386
Domiciled in
IL
Incorporated in
IL

Valuation

Title
ILS in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT